04.02.21 -- Designing An Optimal APAC Clinical Supply Chain

Time is critical in today’s highly competitive drug development environment. This Q&A discusses approaches for faster development timelines, including adopting a single-vendor method with a cross-integrated team, engaging experts early in the development cycle, and performing steps in parallel.

New clinical trial challenges are emerging, including transforming the clinical supply chain from relatively fixed and site-centric to flexible to respond to changes in patient demand. This webinar explores how innovations in forecasting, supply pooling, decentralized processing, labeling, demand-led supply, and direct-to-patient distribution are converging to create a next-generation clinical supply chain that is flexible, lean, and patient-centric.

With clinical study activity increasing in the Asia-Pacific (APAC) region, it is important for sponsors across the globe to understand the area landscape to develop a distribution strategy that avoids delays and minimizes cost and risk. Learn how to navigate complexities throughout the region.